Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

DaVita Venture Group

Investor type Corporate Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 5
Average round size
The average size of a deal this fund participated in
Portfolio companies 5
Rounds per year 1.67
Lead investments 1
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Medical
  • Biotechnology
  • mHealth
  • Personal Health

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of DaVita Venture Group:
Typical Co-investors
DaVita Venture Group is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after DaVita Venture Group:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
15K Angels -
Asterisk Ventures -
Aurum Land Central Region, Singapore, Singapore
Camac Partners New York, New York, United States
CGS Holding -
Constant Capital Accra, Ghana, Greater Accra
Dimensional Fund Advisors Austin, Texas, United States
Early Light Ventures Baltimore, Maryland, United States
Finnovista Madrid, Madrid, Spain
Freestyle Interactive -
GenomePrecision Beijing, Beijing, China
Huixin Capital China, Hong Kong, Hong Kong Island
Hunan Xingxiang Investment Changsha, China, Jiangsu
Korea Investment Holdings Seoul, Seoul-t'ukpyolsi, South Korea
Lekker Energie Berlin, Berlin, Germany
Lumina Datamatics Minnesota, Plymouth, United States
OneAngstrom -
Topband China, Guangdong, Shenzhen
Twins Partners -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Pathalys Pharma

$11M22 Jun 2021 Raleigh, North Carolina, United States

Heartbeat Health

Health Care
$20M10 May 2021 New York, New York, United States


Health Care
Health Diagnostics
$16M16 Mar 2021 Brisbane, California, United States


Health Care
$17M15 Dec 2020 Los Angeles, California, United States


Health Care
Information Technology
Personal Health
$10M06 May 2020 Los Angeles, California, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent DaVita Venture Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: